Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Newronika

Newronika
2008 FOUNDED
PRIVATE STATUS
Series A LATEST DEAL TYPE
$9.3M LATEST DEAL AMOUNT
8 INVESTORS
Description

Developer of neuromodulation therapies created to restores brain and body functioning. The company's therapies uses retroactivity system to record brain activity and modulate neurostimulation to collect, analyze and interpret biosignals, enabling patients to receive the right stimulation at the right moment to perform normal daily activities and improve quality of life.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Other Healthcare Technology Systems
Primary Office
  • Via Dante 4
  • 20121 Milan
  • Italy

+39 02 0000 0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Newronika’s full profile, request a free trial.

Newronika Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC (Series A) 25-Sep-2019 $9.3M 000.00 Completed Generating Revenue
2. Later Stage VC 14-Jun-2016 00.000 00.000 Completed Generating Revenue
1. Angel (individual) 01-Jan-2008 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Newronika Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Omnes Capital PE/Buyout Minority 000 0000 000000 0
Atlante Ventures Venture Capital Minority 000 0000 000000 0
F3F Other Minority 000 0000 000000 0
IMI Investimenti PE/Buyout Minority 000 0000 000000 0
Indaco Venture Partners Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »

Newronika Executive Team (6)

Name Title Board
Seat
Contact
Info
Lorenzo Rossi Ph.D Co-Founder, Board Member & Chief Executive Officer
Laura Ferro President & Board Member
Alain Garcinuño Chief Financial Officer, Investors Relations & Business Development
Fabio Grisoni Chief Strategic Officer
Alberto Priori Ph.D Co-Founder, Board Member & Chairman of Scientific Board
You’re viewing 5 of 6 executives. Get the full list »

Newronika Board Members (5)

Name Representing Role Since Contact
Info
Alberto Priori Ph.D Newronika Co-Founder, Board Member & Chairman of Scientific Board 000 0000
Claudio Rumazza Innogest Capital Board Member 000 0000
Laura Ferro Newronika President & Board Member 000 0000
Lorenzo Rossi Ph.D Newronika Co-Founder, Board Member & Chief Executive Officer 000 0000
Sergio Barbieri Self Board Member 000 0000